RESUMO
INTRODUCTION: The presence of postoperative seromadesis is common, corresponding to the presence of serum in the subcutaneous tissue post a surgical event. Erythromycin has been reported as sclerosing, although not in orthopedic surgery. We report a case of erythromycin seromadesis in orthopedic surgery. CASE PRESENTATION: We present a case of a 63-year-old woman having undergone femoral prosthesis surgery and total hip replacement with a subfacial seroma without findings of infection, refractory to standard treatment of compression bandages, massage and cleaning surgery in two oportunities. A literature review was undertaken to obtain the therapeutic alternatives where erythromycin seromadesis is chosen with excellent response. CONCLUSION: Erythromycin sclerotherapy should be considered as an effective and safe option in the treatment of seroma in general surgery and traumatology. More studies are necessary to get a better evidence. We believe that this is the first study of use of erythromycin as sclerotherapy in a traumatology case.
RESUMO
INTRODUCTION: Intraosseous lipomas are the most infrequent primary bone tumor, lesions are mainly asymptomatic and generally diagnosed incidentally, and there is controversy about the management. Here, we present a surgery solution that has not been described previously in literature. CASE PRESENTATION: A 23-year-old female without previous morbid history consults a general physician because of unspecific left hip pain when walking, not related to any previous trauma or any other symptoms. In her study, radiography of the sore hip showed a radiopaque lesion with lithic aspect at the neck of the left femur. CONCLUSION: Intraosseous lipoma, in spite of being a rare condition, can be diagnosed incidentally by its radiologic characteristics. The treatment can be based on observation or surgery in particular cases objectified by clinic and Mirel score.
RESUMO
El síndrome urémico hemolítico afecta principalmente a pacientes en edad pediátrica. Se caracteriza por la triada de anemia hemolítica microangiopática, trombocitopenia e insuficiencia renal aguda. Se reconocen múltiples agentes etiológicos de síndrome urémico hemolítico, aunque se considera a la infección por Escherichia coli enterohemorrágica como la principal etiología. La gran mayoría de los brotes epidémicos y casos esporádicos en humanos se han asociado con el serotipo 0157:H7...
Hemolytic uremic syndrome (HUS) is a disease primarily of infancy and early childhood. It is characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. Numerous etiologic factors have been associated with hemolytic uremia syndrome but the infection with enterohemorrhagic Escherichia Coli is considered the most common cause. The majority of outbreaks and sporadic cases in humans have been associated with serotype 0157:H7...
